These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 15729383)

  • 21. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directing oncogenic fusion genes into stem cells via an SCL enhancer.
    Eguchi M; Eguchi-Ishimae M; Green A; Enver T; Greaves M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1133-8. PubMed ID: 15650051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TEL-JAK2 transgenic mice develop T-cell leukemia.
    Carron C; Cormier F; Janin A; Lacronique V; Giovannini M; Daniel MT; Bernard O; Ghysdael J
    Blood; 2000 Jun; 95(12):3891-9. PubMed ID: 10845925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML.
    Maeda T; Yagasaki F; Ishikawa M; Takahashi N; Bessho M
    Blood; 2005 Mar; 105(5):2115-23. PubMed ID: 15514005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.
    Chen J; Williams IR; Kutok JL; Duclos N; Anastasiadou E; Masters SC; Fu H; Gilliland DG
    Blood; 2004 Jul; 104(2):535-42. PubMed ID: 15054045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the TEL-Syk fusion protein in hematopoietic stem cells leads to rapidly fatal myelofibrosis in mice.
    Graham MT; Abram CL; Hu Y; Lowell CA
    PLoS One; 2013; 8(10):e77542. PubMed ID: 24116232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta).
    Bourgeade MF; Défachelles AS; Cayre YE
    Blood; 1998 May; 91(9):3333-9. PubMed ID: 9558390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.
    Toffalini F; Hellberg C; Demoulin JB
    J Biol Chem; 2010 Apr; 285(16):12268-78. PubMed ID: 20164181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Abl/Arg substrate ArgBP2/nArgBP2 coordinates the function of multiple regulatory mechanisms converging on the actin cytoskeleton.
    Cestra G; Toomre D; Chang S; De Camilli P
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1731-6. PubMed ID: 15659545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-omic analysis reveals HIP-55-dependent regulation of cytokines release.
    Jiang Y; Xing Z; Zhu B; Wang W; Sun Y; Shi Z; Li Z
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32134471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
    Okuda K; Golub TR; Gilliland DG; Griffin JD
    Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell stimulation by interleukin 3 is a novel process of signal transduction: the rolling cell cycle and its implications for leukemic transformation.
    Garland JM; Kinnaird A; Elliott K
    Leukemia; 1988 Jul; 2(7):476-80. PubMed ID: 3292849
    [No Abstract]   [Full Text] [Related]  

  • 34. Signal transduction and cellular functions of the TEL/ARG oncoprotein.
    Okuda K; Oda A; Sato Y; Nakayama A; Fujita H; Sonoda Y; Griffin JD
    Leukemia; 2005 Apr; 19(4):603-10. PubMed ID: 15729383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors.
    Okuda K; Sato Y; Sonoda Y; Griffin JD
    Int J Hematol; 2004 Feb; 79(2):138-46. PubMed ID: 15005341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.